Russell 1000 Value Ishares ETF (IWD)

$159.77 2.23 (1.38%)

11:49 EST IWD Stock Quote Delayed 30 Minutes

7 Cheap Value Stocks to Buy for August 2021

By Tezcan Gecgil, InvestorPlace Contributor Jul 27, 2021

These cheap value stocks have the potential to provide shareholders with long-term growth that exceeds their current limiting valuations.

7 Best Stocks To Buy To Hedge Against A Potential Downturn

The 7 Best Stocks and Cryptos to Buy in May

7 Undervalued Stocks to Buy Before the Bounce

More Articles

Volume:

Previous Close -

Market Cap 561.27M

PE Ratio -

EPS -

Volume (Avg. Vol.) 2.28M

Day's Range $157.77 - $160.55

52-Week Range $134.89 - $171.42

Dividend & Yield $2.82 (1.77%)

IWD Stock Predictions, Articles, and Russell 1000 Value Ishares ETF News

From InvestorPlace
From the Web

7 Value Stocks Everyone Is Ignoring

By Tezcan Gecgil, InvestorPlace Contributor Mar 24, 2021

Blue chips and companies on the rebound. Here are seven of the best value stocks for long-term investors.

7 Value Stocks Ready for the Next 10 Years

By Tezcan Gecgil, InvestorPlace Contributor Mar 1, 2021

These seven value stocks offer solid investment opportunities for value-conscious, patient investors with long-term portfolios.

7 Blue-Chip Stocks With Gains and Pedigree

By Tezcan Gecgil, InvestorPlace Contributor Feb 9, 2021

These seven blue chip stocks are among the most stable and the best dividend-paying firms

Make the Shift Toward Value Stocks With These 5 Picks

By Aaron Levitt, InvestorPlace Contributor Dec 19, 2019

Value stocks are hot these days, and the best part is the shift toward them isn't stopping anytime soon. Here are five to buy today.

The 10 Most Expensive Stocks In The S&P 500

By Matt Hogan, Founder, Finbox.io Jan 24, 2018

These ten stocks are currently the most expensive stocks trading on the S&P 500 -- so buyer beware.

Value ETFs and Stocks to Buy on Tax Cut Delay Concerns

By Zacks Investment Research Nov 13, 2017

The stock market has experienced sell-off in the last couple of days stemmed from concerns over the delay in the implementation of corporate tax cuts.

6 ETFs You Must Dump Immediately

By Lawrence Meyers, InvestorPlace Contributor Jul 5, 2017

Some ETFs are great and can work wonders in your portfolio. But the ones in this list are ETFs to sell, and now, because they're unlikely to be helping.

It’s Time to Give Value Stocks Another Look

By Daniel Putnam, InvestorPlace Contributor Nov 17, 2015

Value stocks have underperformed growth stocks in 2015, but several factors indicate that value could be a winner in the coming year.

One ETF With Notable Outflow

By ETFChannel.com Mar 18, 2015

Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings.

2022 Market Forecasts: Sell In May And Go Away?

From Talk Markets Jan 4, 2022

The S&P 500 will begin the first half of 2022 in the black but to finish in the red. Growth will outperform value but small-cap will enjoy a resurgence.

Case Study On ETFs Leveling The Field For Active Management

From Talk Markets Nov 17, 2021

With a deluge of actively managed ETFs launching in 2021, are they all doomed to fail to outperform the benchmark indices just as such funds in the trraditional structure have? This case study attempts to shed some light on this subject.

Market Forecasts For 4th Quarter 2021 And Beyond

From Talk Markets Oct 20, 2021

1-, 3-, 6- and 12-month forecasts for S&P 500, MidCap, Small Cap, Growth, Value and Nasdaq-100.

5 Winning ETF Ideas for the Fourth Quarter

From Talk Markets Oct 13, 2021

Here are some investing ideas that could prove to be extremely beneficial for investors in the fourth quarter.

Positioning In SmileDirectClub Highest On Record

From Talk Markets Sep 25, 2021

Let's take a look at this week's short interest trends among some of the most widely followed high-short-float stocks.

Look For The Q4 Biotech Bounce In Mid-Small Caps

From Talk Markets Sep 17, 2021

Large-cap biopharma stocks are off their highs because of prospects that drug prices may be directly negotiated through Medicare but several Democrats are not in agreement as to how this could be best accomplished.